| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Olema Pharmaceuticals, Inc. (OLMA) has 17 insiders with recent SEC Form 4 filings, including 1 buy and 24 sells. OLMA is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 737.8K | $11.00M | - | |
| CEO | 275.0K | $4.10M | - | |
| Other | 250.0K | $3.73M | - | |
| Other | 139.7K | $2.08M | - | |
| Other | 106.3K | $1.58M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 15, 2026 | Kovacs Shane William Charles66 | Ch. Operating &Financial Off. | Sell | 103,822 | $28.70 | $2,980,054.22 | -21.5% | -44.8% | - | |
| Jan 14, 2026 | Harmon Cyrus72 | Director | Sell | 3,489 | $29.12 | $101,599.68 | -0.5% | -44.0% | - | |
| Jan 14, 2026 | Myles David C.69 | Ch. Discov. &Non-clin Dev Off | Sale+OE | 110,000 | $28.25 | $3,107,229.17 | -4.5% | -44.0% | - | |
| Dec 23, 2025 | Zojwalla Naseem56 | Chief Medical Officer | Sale+OE | 269,509 | $27.94 | $7,530,147.84 | -49.1% | -49.5% | - | |
| Dec 22, 2025 | Harmon Cyrus72 | Director | Sell | 2,881 | $28.53 | $82,194.93 | -0.4% | -50.4% | - | |
| Dec 19, 2025 | Myles David C.69 | Ch. Discov. &Non-clin Dev Off | Sell | 51,000 | $30.46 | $1,553,543.54 | -2.9% | -46.4% | - | |
| Dec 19, 2025 | Clark Ian T72 | Director | Sale+OE | 264,800 | $29.73 | $7,873,109.28 | -48.9% | -46.4% | - | |
| Sep 18, 2025 | Harmon Cyrus72 | Director | Sell | 25,000 | $8.19 | $204,840.64 | -1.4% | +283.1% | - | |
| Jan 8, 2025 | Bain Capital Life Sciences Investors, LLC | 10% Owner | Buy | 300,000 | $5.76 | $1,727,370.00 | +4.0% | -46.8% | +344.7% | |
| Dec 17, 2024 | Graham G. Walmsley48 | Director | Sell | 700,761 | $6.75 | $4,730,136.75 | -100% | -27.5% | +430.9% |